During the COVID-19 pandemic, pharmacists have increasingly played a key role as being the first point of contact for people with wounds, both chronic and acute. As the burden of wound care increases through the aging population and with many people being reluctant to go into the hospital or primary care setting, this key role
A study has found that a new 'care bundle' can reduce the incidence of facial pressure injuries in frontline COVID-19 healthcare workers caused by the prolonged wearing of Personal Protective Equipment (PPE). The study, led by researchers from RCSI University of Medicine and Health Sciences Skin Wounds and Trauma (SWaT) Research Centre, is published in
Indiana University researchers have discovered that a chemical compound found in essential oils improves the healing process in mice when it is topically applied to a skin wound—a finding that could lead to improved treatments for skin injuries in humans. IU scientists also reported that skin tissue treated with the chemical compound, beta-carophyllene—which is found
The American population is aging, and conditions such as diabetes and cardiovascular disease are on the rise. With those factors in place, the medical community has growing concerns about wound treatment. According to the American Professional Wound Care Association, about 15 percent of Medicare recipients suffer chronic, nonhealing wounds with an annual cost of about
About one decade after its first benefit assessment of negative pressure wound therapy (NPWT), the German Institute for Quality and Efficiency in Health Care (IQWiG) is reassessing this treatment method. However, then as now, its benefit and harm are unclear. Whereas only few studies with very limited informative value were available in 2006, over 100
(HealthDay)—There does not appear to be a clinically meaningful association between baseline or prospective hemoglobin A1c (A1C) and wound healing in patients with diabetic foot ulcers (DFUs), according to a study published online April 16 in Diabetes Care. Betiel K. Fesseha, M.D., from Johns Hopkins University in Baltimore, and colleagues retrospectively evaluated the association between
A Purdue University-patented technology shows promise in using microscopic bubbles filled with oxygen to help with various medical treatments, including improving cancer therapeutics and helping wounds heal faster. Samara Biotech LLC, a Purdue startup, has developed an easy-to-use method to inject oxygen “nanobubbles” intravenously so they can be targeted precisely at wounds or cancerous tumors.
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok